Bharat Biotech

Government-owned BIBCOL to produce 2 crore COVAXIN doses every month

12 May 2021

Government-owned BIBCOL to produce 2 crore COVAXIN doses every month

To accelerate the production of COVAXIN—the indigenous COVID-19 vaccine developed by Hyderabad-based Bharat Biotech—amid severe vaccine shortage in India, the Centre on Wednesday reportedly gave its nod for production of COVAXIN at government-owned Bharat Immunologicals & Biologicals Corporation Limited (BIBCOL) in Uttar Pradesh's Bulandshahr.

12 May 2021

COVAXIN phase 2/3 trials for 2-18-year-olds recommended by expert panel

In a bid to extend the country's vaccination drive to include people below 18 years, an expert panel on Tuesday recommended Hyderabad-based Bharat Biotech's COVID-19 vaccine COVAXIN for phase 2/3 clinical trials on children and adolescents aged two to 18 years.

01 May 2021

Truck laden with COVAXIN abandoned for 12 hours, driver missing

A truck carrying 2.40 lakh doses of COVAXIN worth Rs. 8 crore was left parked for nearly 12 hours after its driver went missing under mysterious circumstances in Madhya Pradesh's Narsinghpur district.

29 Apr 2021

Bharat Biotech reduces COVAXIN price to Rs. 400 for states

Hyderabad-based pharmaceutical company Bharat Biotech on Thursday reduced the price of its COVID-19 vaccine, COVAXIN, for state governments.

20 Apr 2021

Bharat Biotech to produce 700 million COVAXIN doses per year

To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, COVAXIN, to 700 million doses per annum, the vaccine maker said on Tuesday.

31 Mar 2021

COVAXIN manufacturing facility fails to meet CGMP standards: Brazilian regulator

The Brazilian health regulator Anvisa denied permission to import Bharat Biotech's COVID-19 vaccine COVAXIN into the country after its authorities found that the plant in which the vaccine is being made did not meet the Current Good Manufacturing Practice requirements.

20 Mar 2021

Nepal gives emergency use approval to Bharat Biotech's COVAXIN

Nepal's national drug regulatory authority on Saturday granted emergency use approval to Bharat Biotech's COVAXIN, becoming the third country to approve India's indigenously developed COVID-19 vaccine.

09 Mar 2021

COVAXIN Phase-II trial interim data shows better reactogenicity, safety: Lancet

COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech, has shown better reactogenicity and safety, Phase II trial interim data published in The Lancet journal showed.

04 Mar 2021

Delhi HC pulls up Centre for exporting COVID-19 vaccines

The Delhi High Court on Thursday pulled up the central government over restricted COVID-19 vaccinations in India, even as vaccine exports to other nations continue.

03 Mar 2021

COVAXIN 81% effective, offers protection against UK variant: Bharat Biotech

COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech, has been found to have 81% interim efficacy against preventing infections, the company said on Wednesday.

30 Jan 2021

A year into pandemic, India's death toll drops to fourth-highest

As India's battle against coronavirus logged one year on Saturday, the nation slipped on the death toll index, going from the third to fourth position.

27 Jan 2021

COVAXIN may neutralize UK strain of COVID-19: Review report

COVAXIN, developed by Bharat Biotech, has the ability to neutralize the UK variant of the coronavirus, according to a pre-print review by bioRxiv, a free online archive and distribution service for unpublished pre-prints in the life sciences.

26 Jan 2021

Diplomats, including from Pakistan and China, offered coronavirus vaccines

After starting its vaccination drive on January 16, New Delhi has offered made-in-India vaccines to diplomatic corps, including to those from Pakistan and China.

24 Jan 2021

Coronavirus: Nearly 16 lakh vaccinated in India as pace accelerates

As the first phase of COVID-19 vaccinations is underway in India, nearly 16 lakh healthcare and frontline workers have been inoculated, government data showed.

22 Jan 2021

Swachh Bharat helped fight coronavirus: Modi to vaccine recipients

Prime Minister Narendra Modi on Friday said that his government's 'Swachh Bharat' cleanliness mission helped in the fight against the coronavirus.

21 Jan 2021

Coronavirus: PM Modi, CMs to get vaccinated in second phase

Prime Minister Narendra Modi, 70, would be getting the coronavirus vaccine shot in the second phase of the drive launched last week, reports said on Thursday.

20 Jan 2021

Panel recommends permission for Phase I Intranasal COVID-19 vaccine trial

An expert panel, Central Drugs Standard Control Organisation, (CDSCO) on Tuesday recommended granting permission for conducting the Phase I clinical trial of an intranasal vaccine against COVID-19 developed by Bharat Biotech, official sources said.

19 Jan 2021

Maldives to become first foreign country to receive Covishield doses

Maldives is set to become the first foreign country to receive COVID-19 vaccines from India. The Asian country will reportedly receive a consignment of Covishield doses on Wednesday.

19 Jan 2021

Centre issues a new Letter of Comfort to Bharat Biotech

Bharat Biotech secured a fresh Letter of Comfort from the Centre for 45 lakh doses of its COVID-19 vaccine, COVAXIN.

19 Jan 2021

Who shouldn't take COVAXIN? Maker Bharat Biotech issues fact-sheet

Two days after India started its coronavirus vaccination program, Hyderabad-based Bharat Biotech released guidelines revealing who should receive shots of COVAXIN.

17 Jan 2021

Co-WIN app suffers glitches on 1st day of vaccination drive

The COVID-19 Vaccine Intelligence Network (Co-WIN) platform suffered several glitches on the first day of India's vaccination drive.

17 Jan 2021

Meet India's frontline workers who received first COVID-19 vaccine shots

On Saturday, India launched its COVID-19 vaccination drive, inoculating 1.91 lakh people on the first day alone.

13 Jan 2021

COVAXIN shipped to eleven cities in India: Bharat Biotech

Bharat Biotech, on Wednesday, said that it has successfully air-shipped its COVID-19 vaccine COVAXIN to eleven cities in India in the early hours. It has also donated 16.5 lakh doses to the Centre.

11 Jan 2021

Centre will sponsor vaccination of healthcare, frontline workers: PM Modi

In his first interaction with chief ministers of all states after India approved two vaccines, Prime Minister Narendra Modi said the federal government will sponsor the vaccination of three crore healthcare and frontline workers.

10 Jan 2021

Delhi identifies 89 sites for COVID-19 vaccination drive: Health Minister

The Delhi government has identified 89 sites for the COVID-19 vaccination drive in the national capital, Health Minister Satyendar Jain said on Sunday.

09 Jan 2021

Days after participating in vaccine trial, man dies in Bhopal

A 42-year-old volunteer named Deepak Marawi, from Bhopal in Madhya Pradesh died nearly ten days after he participated in the clinical trial for COVAXIN held at a private hospital, its vice-chancellor said on Saturday.

08 Jan 2021

Severe side-effects after COVID-19 vaccine: What are your legal options?

India is looking forward to launching a massive COVID-19 vaccination drive with two vaccines that have been granted emergency use authorization (EUA).

07 Jan 2021

COVID-19 vaccine transport to start soon; government readies plan

The central government has prepared a detailed draft for the transport of vaccines across India ahead of a nationwide roll-out.

07 Jan 2021

Ahead of nationwide exercise, COVID-19 vaccine dry run in Haryana

A dry run of the COVID-19 vaccine roll-out was conducted in Haryana on Thursday, a day before the exercise will be conducted across India.

05 Jan 2021

Sleeves up! Coronavirus vaccination drive could begin on January 13

The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.

05 Jan 2021

Global leaders hail India's scientific innovation to combat COVID-19

Global leaders have lauded India's leadership in scientific innovation and decisive action to combat the COVID-19 pandemic.

05 Jan 2021

SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

04 Jan 2021

COVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns

Bharat Biotech MS Krishna Ella on Monday said the company has "tremendous experience" in developing vaccines and their vaccine, COVAXIN, is "200% safe."

04 Jan 2021

Bharat Biotech allowed COVAXIN trials on children aged 12+

Hyderabad-based pharmaceutical company Bharat Biotech has been allowed to conduct clinical trials for its COVID-19 vaccine on children above the age of 12.

03 Jan 2021

All you need to know about vaccines approved in India

Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.

03 Jan 2021

SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI

Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.

03 Jan 2021

Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod

A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.

02 Jan 2021

All states to hold dry run for coronavirus vaccination today

A dry run for vaccination, before the actual doses of the coronavirus vaccine are administered to people, will be held in all states and union territories today.

01 Jan 2021

India set to start COVID-19 vaccination; panel approves Oxford vaccine

In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.

01 Jan 2021

India could approve coronavirus vaccine soon, key meeting today

After the meeting on Wednesday to judge the emergency use authorization applications of coronavirus vaccine developers remained without a conclusion, the subject expert committee (SEC) will meet again today.

Latest News


Popular timelines

Download App
Stay Updated